Study shows strong long-term survival rates for patients with GIST

No Comment 0 View

Nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years, a new report outlines.



Source link

In : Health

About the author

Leave a Reply

Your email address will not be published. Required fields are marked (required)